Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 22 October 2004: Vol. 306. no. 5696, pp. 687 - 690 DOI: 10.1126/science.1098992
|
|
Reports
A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes
L. E. Olson,1*
J. T. Richtsmeier,2
J. Leszl,2
R. H. Reeves1
The "Down syndrome critical region" (DSCR) is a chromosome 21 segment purported to contain genes responsible for many features of Down syndrome (DS), including craniofacial dysmorphology. We used chromosome engineering to create mice that were trisomic or monosomic for only the mouse chromosome segment orthologous to the DSCR and assessed dysmorphologies of the craniofacial skeleton that show direct parallels with DS in mice with a larger segmental trisomy. The DSCR genes were not sufficient and were largely not necessary to produce the facial phenotype. These results refute specific predictions of the prevailing hypothesis of gene action in DS.
1 Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
2 Department of Anthropology and Program in Genetics, Pennsylvania State University, University Park, PA 16802, USA.
* Present address: Department of Biology, University of Redlands, Redlands, CA 92373, USA.
To whom correspondence should be addressed. E-mail: rreeves{at}jhmi.edu
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome.
- M. Dierssen, Y. Herault, and X. Estivill (2009)
Physiol Rev
89, 887-920
| Abstract »
| Full Text »
| PDF »
- The "Down Syndrome Critical Region" Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome.
- N. P. Belichenko, P. V. Belichenko, A. M. Kleschevnikov, A. Salehi, R. H. Reeves, and W. C. Mobley (2009)
J. Neurosci.
29, 5938-5948
| Abstract »
| Full Text »
| PDF »
- Down syndrome--recent progress and future prospects.
- F. K. Wiseman, K. A. Alford, V. L.J. Tybulewicz, and E. M.C. Fisher (2009)
Hum. Mol. Genet.
18, R75-R83
| Abstract »
| Full Text »
| PDF »
- Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.
- S. Malinge, S. Izraeli, and J. D. Crispino (2009)
Blood
113, 2619-2628
| Abstract »
| Full Text »
| PDF »
- Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.
- F. Liu, Z. Liang, J. Wegiel, Y.-W. Hwang, K. Iqbal, I. Grundke-Iqbal, N. Ramakrishna, and C.-X. Gong (2008)
FASEB J
22, 3224-3233
| Abstract »
| Full Text »
| PDF »
- Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
- G. Kirsammer, S. Jilani, H. Liu, E. Davis, S. Gurbuxani, M. M. Le Beau, and J. D. Crispino (2008)
Blood
111, 767-775
| Abstract »
| Full Text »
| PDF »
- Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses.
- V. Besson, V. Brault, A. Duchon, D. Togbe, J.-C. Bizot, V. F.J. Quesniaux, B. Ryffel, and Y. Herault (2007)
Hum. Mol. Genet.
16, 2040-2052
| Abstract »
| Full Text »
| PDF »
- Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities.
- Z. Li, T. Yu, M. Morishima, A. Pao, J. LaDuca, J. Conroy, N. Nowak, S.-I. Matsui, I. Shiraishi, and Y. E. Yu (2007)
Hum. Mol. Genet.
16, 1359-1366
| Abstract »
| Full Text »
| PDF »
- Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
- L. E. Olson, R. J. Roper, C. L. Sengstaken, E. A. Peterson, V. Aquino, Z. Galdzicki, R. Siarey, M. Pletnikov, T. H. Moran, and R. H. Reeves (2007)
Hum. Mol. Genet.
16, 774-782
| Abstract »
| Full Text »
| PDF »
- Ts65Dn, a Mouse Model of Down Syndrome, Exhibits Increased GABAB-Induced Potassium Current.
- T. K. Best, R. J. Siarey, and Z. Galdzicki (2007)
J Neurophysiol
97, 892-900
| Abstract »
| Full Text »
| PDF »
- New techniques to understand chromosome dosage: mouse models of aneuploidy.
- V. L.J. Tybulewicz and E. M.C. Fisher (2006)
Hum. Mol. Genet.
15, R103-R109
| Abstract »
| Full Text »
| PDF »
- Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells.
- M. W. Lensch and G. Q. Daley (2006)
Blood
107, 2605-2612
| Abstract »
| Full Text »
| PDF »
- An Aneuploid Mouse Strain Carrying Human Chromosome 21 with Down Syndrome Phenotypes.
- A. O'Doherty, S. Ruf, C. Mulligan, V. Hildreth, M. L. Errington, S. Cooke, A. Sesay, S. Modino, L. Vanes, D. Hernandez, et al. (2005)
Science
309, 2033-2037
| Abstract »
| Full Text »
| PDF »
- Dissecting the genetic complexity of human 6p deletion syndromes by using a region-specific, phenotype-driven mouse screen.
- D. Bogani, C. Willoughby, J. Davies, K. Kaur, G. Mirza, A. Paudyal, H. Haines, R. McKeone, M. Cadman, G. Pieles, et al. (2005)
PNAS
102, 12477-12482
| Abstract »
| Full Text »
| PDF »
- Segmental trisomy of chromosome 17: A mouse model of human aneuploidy syndromes.
- T. Vacik, M. Ort, S. Gregorova, P. Strnad, R. Blatny, N. Conte, A. Bradley, J. Bures, and J. Forejt (2005)
PNAS
102, 4500-4505
| Abstract »
| Full Text »
| PDF »
- The Goldilocks Genes.
- M. Leslie (2004)
Sci. Aging Knowl. Environ.
2004, ns8
| Abstract »
| Full Text »
| PDF »
|
|